Скачать или смотреть BioStock | AlzeCure | CEO interview about the company's development and the rights issue | 2022

BioStock interviews Martin Jönsson , CEO of AlzeCure, about the company's mission and the rights issue.

0:00 Introduction
0:22 Overview of the company's development and pipeline
1:55 Difference between AlzeCure's Alzheimer's treatments and today's treatments?
3:14 When to start treatment with Alzstatin
3:58 Why is it so difficult to develop a treatment for Alzheimer's
5:15 Scientific advisors and KOLs
6:12 Allocation of the raised capital

AlzeCure Pharma develops a portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain.
Read BioStock's latest article:
https://www.biostock.se/2022/03/alzec...

Also watch AlzeCure's CEO Martin Jönsson present the company at BioStock Investor Meeting in March 2022:    • BioStock Investor Meeting March 2022 | Alz...  

Subscribe and follow BioStock on:
YouTube https://bit.ly/Biostock
LinkedIn:   / biostock  
Facebook:   / biostock.se  
Twitter:   / biostock_swe  
https://www.biostock.se/
#biostock #lifescience #AlzeCure

About BioStock
BioStock is Scandinavia's leading digital news and analysis service with an exclusive focus on the Life Science sector. Our primary editorial office is found at Medicon Village in Lund, one of Sweden's foremost innovation clusters for life science companies, while our second editorial office is located in central Stockholm with proximity to both life science companies and financial players. We have TV studios on both sites.